A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis
Clinical trial NCT04633447 · TERMINATED
Trial details
- NCT number
- NCT04633447
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2024-05-22
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.